Dithiocarbamates as potent inhibitors of nuclear factor κb activation in intact cells

Journal of Experimental Medicine

Volumn 175, Issue 5, 1992, Pages 1181-1194

  Schreck, Ralf ^a   Meier, Beate ^a,b   Männel, Daniela N ^a,c   Dröge, Wulf ^a,c   Baeuerle, Patrick A ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1,10 PHENANTHROLINE; BACTERIUM LIPOPOLYSACCHARIDE; CHELATING AGENT; DEFEROXAMINE; DITHIOCARBAMIC ACID DERIVATIVE; HYDROGEN PEROXIDE; INTERLEUKIN 1; METAL CHELATE; NUCLEAR FACTOR; OXYGEN RADICAL; PHORBOL ESTER; PYRROLIDINE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; DNA BINDING; DRUG MECHANISM; ENHANCER REGION; GENE ACTIVATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; PRIORITY JOURNAL; REPORTER GENE; SIGNAL PROCESSING; SIMIAN VIRUS 40; VIRUS EXPRESSION;

BASE SEQUENCE; CELL LINE; CHELATING AGENTS; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMAN; LIPOPOLYSACCHARIDES; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PYRROLIDINES; SUPEROXIDES; SUPPORT, NON-U.S. GOV'T; THIOCARBAMATES; TRANS-ACTIVATION (GENETICS);

EID: 0026590541     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.175.5.1181     Document Type: Article

References (81)

1. Baeuerle, P.A., and D. Baltimore. 1991. The physiology of the NF-kB transcription factor. In Molecular Aspects of Cellular Regulation, Hormonal Control Regulation of Gene Transcription. P. Cohen and J.G. Foulkes, editor. Elsevier Science Publishers B.V., Amsterdam. 409-432.
2. Baeuerle, P.A. 1991. The inducible transcription factor NF-kB: regulation by distinct subunits. Biochem. Biophys. Acta. 1072:63.
3. Baeuerle, P.A., and D. Baltimore. 1988a. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kB transcription factor. Cell. 53:211.
4. Urban, M.B., R. Schreck, and P.A. Baeuerle. 1991. NF-kB contacts DNA by a heterodimer of the p50 and p65 subunit. EMBO (Eur. Mol. Biol. Organ.) J. 10:1817.
5. Meichle, A., S. Schütze, G. Hensel, D. Brunsing, and M. Krönke. 1990. Protein kinase C-independent activation of nuclear factor kB by tumor necrosis factor. J. Biol. Chem. 265:8339.
6. Bomsztyk, K., J.W. Rooney, T. Iwasaki, N.A. Rachie, S.K. Dower, and C. Hopkins Sibley. 1991. Evidence that interleukin-1 and phorbol esters activate NF-kB by different pathways: role of protein kinase C. Cell Regul. 2:329.
7. Schreck, R., P. Rieber, and P.A. Baeuerle. 1991. Reactive oxygen intermediates as apparently widely used second messengers in the activation of the NF-kB transcription factor and HIV-1. EMBO (Eur. Mol. Biol. Organ.) J. 10:2247.
8. Staal, F.J.T., M. Roederer, L.A. Herzenberg, and L.A. Herzenberg. 1990. Intracellular thiols regulate activation of nuclear factor kB and transcription of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA. 87:9943.
9. Mihm, S., J. Ennen, U. Pessara, R. Kurth, and W. Dröge. 1991. Inhibition of HIV-1 replication and NF-kB activity by cysteine and cysteine derivatives. AIDS (Phila.). 5:497.
10. Perchellet, E.M., E.A. Matta, and N.L. Abney. 1987. Effects of diverse intracellular thiol delivery agents on glutathione peroxidase activity, the ratio of reduced/oxidized glutathione, and ornithine decarboxylase induction in isolated mouse epidermal cells treated with 12-0-tetradecanoyl-phorbol-13-acetate.J. Cell. Physiol. 131:64.
11. Sando, J.J., M.L. Hilfiker, D.S. Salomon, and J.J. Farrar. 1981. Specific receptors for phorbol esters in lymphoid cell populations: role in enhanced production of T-cell growth factor. Proc Natl. Acad. Sci. USA. 78:1189.
12. Fischer, S.M., and L.M. Adams. 1985. Suppression of tumor promoter-induced chemiluminescence in mouse epidermal cells by several inhibitors of arachidonic acid metabolism. Cancer Res. 45:3130.
13. Bonser, R.W., J. Dawson, N.T. Thompson, H.F. Hodson, and L.G. Garland. 1986. Inhibition of phorbol ester stimulated superoxide production by l-oleoyl-2-acetyl-sn-glycerol (OAG); fact or artefact? FEBS (Fed. Eur. Biochem. Soc.) Lett. 209:134.
14. Meier, B., H.H. Radeke, S. Seile, M. Younes, H. Sies, K. Resch, and G.G. Habermehl. 1989. Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumor necrosis factor-a. Biochem. J. 263:539.
15. Meier, B., H.H. Radeke, S. Seile, G.G. Habermehl, K. Resch, and H. Sies. 1990. Human fibroblasts release low amounts of reactive oxygen intermediates in response to the potent phagocyte stimulants, serum-treated zymosan, N-Formyl-methionyl-leucyl-phenylalanine, leukotriene B4 or 12-o-Tetradecoylphorbol 13-acetate. Biol. Chem. Hoppe-Seyler. 371:1021.
16. Schreck, R., and P.A. Baeuerle. 1991. A role for oxygen radicals as second messengers. Trends Cell Biol. 1:39.
17. Sunderman, F.W., O.E. Paynter, and R.B. George. 1967. The effects of the protracted administration of the chelating agent sodium diethyldithiocarbamate (ditiocarb). Am. J. Med. Sci. 245:46.
18. Lang, J.M., F. Oberling, A. Aleksijevic, A. Falkenrodt, and S. Mayer. 1985. Immunomodulation with diethyldithiocarbamate in patients with AIDS-related-complex. Lancet. 8463:1066.
19. Lang, J.M., J.-L. Touraine, C. Trepo, P. Choutet, M. Kirstetter, A. Falkenrodt, L. Herviou, J.-M. Livrozet, G. Retornaz, F. Touraine, G. Renoux, M. Renoux, M. Musset, J. Caraux, and the AIDS-Imuthiol French Study Group. 1988. Randomized, double-blind, placebo-controlled study of ditiocarb sodium (Im-uthiol) in human immunodeficiency virus infection. Lancet. ii:702.
20. Reisinger, E.C., P. Kern, M. Ernst, P. Bock, H.D. Flad, M. Dietrich, and German DTC Study Group. 1990. Inhibition of HIV progression by ditiocarb. Lancet. 335:679.
21. Hersh, E.M., G. Brewton, D. Abrams, J. Bartlett, J. Galpin, G. Rarkash, R. Gorter, M. Gottlieb, J.J. Jonikas, S. Landesman, A. Levine, A. Marcel, E.A. Petersen, M. Whiteside, J. Zahradnik, C. Negron, F. Boutitie, J. Caraux, J.-M. Dupuy, and L.R. Salmi. 1991. Ditiocarb sodium (Diethyldithiocarbamate) therapy in patients with symptomatic HIV infection and AIDS. J. Am. Med. Assoc 265:1538.
22. Lutz, L.M., E.A. Glonde, and R.O. Recknagel. 1973. Protection by diethyldithiocarbamate against carbontetrachloride lethality in rats and against pulmonary and lymphoid oxygen toxicity. Biochem. Pharmacol. 22:1729.
23. Deneke, S.M., and B.L. Fanburg. 1980. Involvement of glutathione enzymes in oxygen tolerance development by diethyl-dithiocarbamate. Biochem. Pharmacol. 22:1729.
24. Mansour, H., M. Levacher, M.A. Gougerot-Pocidalo, B. Rou-veix, and J. Pocidalo. 1986. Diethyldithiocarbamate provides partial protection against pulmonary and lymphoid oxygen toxicity. J. Pharmacol. Exp Ther. 236:476.
25. Legrand-Poels, S., D. Vaira, J. Pincemail, A. Van de Vorst, and J. Piette. 1990. Activation of human immunodeficiency virus type 1 by oxidative stress. AIDS Res. Hum. Retroviruses. 6:1389.
26. Polonis, V.R., G.R. Anderson, M.T. Vahey, P.J. Morrow, D. Stoler, and R.R. Redfield. 1991. Anoxia induces human immunodeficiency virus expression in infected T cell lines. J. Biol. Chem. 266:11421.
27. Eck, H.-P., H. Gmünder, M. Hartmann, D. Petzoldt, V. Daniel, and W. Dröge. 1989. Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-l-infected patients. Biol. Chem. Hoppe-Seyler. 370:101.
28. Dröge, W., H.-P. Eck, H. Gmünder, and S. Mihm. 1992. Dysregulation of plasma amino acid levels in HIV-infection and cancer and its relevance for the immune system. Amino Acids. In press.
29. Harakeh, S., R.J. Jariwalla, and L. Pauling. 1990. Suppression of human immunodeficiency virus replication by ascorbate in chronically and acutely infected cells. Proc Natl. Acad. Sci. USA. 87:7245.
30. Roederer, M., F.J.T. Staal, P.A. Raju, S.W. Ela, L.A. Herzenberg, and L.A. Herzenberg. 1990. Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Proc Natl. Acad. Sci. USA. 87:4884.
31. Kalebic, T., A. Kinter, G. Poli, M.E. Anderson, A. Meister, and A.S. Fauci. 1991. Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine. Proc Natl. Acad. Sci. USA. 88:986.
32. Nabel, G., and D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (Lond.). 326:711.
33. Englund, G., M.D. Hoggan, T.S. Theodore, and M. Martin. 1991. A novel HIV-1 isolate containing alterations affecting the NF-kB element. Virology. 181:150.
34. Gutteridge, J.M.C., R. Richmond, and B. Halliwell. 1979. Inhibition of the Iron-catalysed formation of hydroxyl radicals from superoxide and of lipid peroxidation by desferrioxiamine. Biochem. J. 184:469.
35. Blake, D.R., N.D. Hall, P.A. Bacon, P.A. Dieppe, B. Halliwell, and J.M.C. Gutteridge. 1983. Effect of a specific iron chelating agent on animal models of inflammation. Ann. Rheum. Dis. 42:89.
36. Sedgwick, A.D., D.R. Blake, P. Winwood, A.R. Moore, A.Y. Al-Duaij, and D. A. Willoughby. 1984. Studies of the iron chelator desferrioxamine on the inflammatory process. Eur. J. Rheumatol. Inflammation. 7:87.
37. Hirscheimann, R., and H. Bekemeier. 1986. Influence of the iron-chelating agent desferrioxiamine on two rat inflammatory models. Free Radical Res. Commun. 2:127.
38. Mello Filho, A.C. de, and R. Meneghini. 1985. Protection of mammalian cells by o-phenanthroline from lethal and DNA-damaging effects produced by active oxygen species. Biochem. Biophys. Acta. 847:82.
39. Crapper McLachlan, D.R., A.J. Dalton, T.P.A. Kruck, M.Y. Bell, W.L. Smith, W. Kalow, and D.F. Andrews. 1991. Intramuscular desferrioxamine in patients with Alzheimer’s disease. Lancet. 337:1304.
40. Miyamato, M., T. Fujita, Y. Kimura, M. Maruyama, H. Harada, Y. Sudo, T. Miyata, and T. Taniguchi. 1988. Regulated expression of a gene encoding nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elements. Cell 54:903.
41. Nabel, G.J., and D. Baltimore. 1990. Correction: An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (Lond.). 344:178.
42. Steiner, C., M. Muller, A. Baniahmad, and R. Renkawitz. 1987. Lysozyme gene activity in chicken macrophages is controlled by positive and negative regulatory elements. Nucleic Acids Res. 14:4163.
43. Zabel, U., R. Schreck, and P. A. Baeuerle. 1991. DNA binding of purified transcription factor NF-kB. J. Biol. Chem. 266:252.
44. Pomerantz, R.J., M.B. Feinberg, D. Trono, and D. Baltimore. 1990. Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression. J. Exp Med. 172:253.
45. Gorman, C.M., L.F. Moffat, and B.H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyl-trans-ferase in mammalian cells. Mol Cell. Biol. 2:1044.
46. Kraft, H. 1989. Ph.D. thesis, University of Heidelberg, Heidelberg, Germany.
47. Hensel, G., D. Mannel, K. Pfizenmaier, and M. Kronke. 1987. Autocrine stimulation of TNF-alpha mRNA expression in HL-60 cells. Lymphokine Res. 6:119.
48. Beauchamp, C., and I. Fridovich. 1972. SOD: improved assays and an assay applicable to acrylamide gels. Anal. Biochem. 44:276.
49. Loschen, G., L. Flohe, and B. Chance. 1971. Respiratory chain linked H2O2 production in pigeon heart mitochondria. FEBS (Fed. Eur. Biochem. Soc) Lett. 18:261.
50. McCord, J.M., and I. Fridovich. 1969. Superoxide dismutase: An enzymatic function of erythrocuprein (hemocuprein). J. Biol. Chem. 244:6049.
51. Cohen, J.D., and H.I. Robins. 1990. Cytotoxicity of diethyldithiocarbamate in human versus rodent cell lines. Invest. New Drugs. 8:137.
52. Osborn, L., S. Kunkel, and G.J. Nabel. 1989. Tumor necrosis factor a and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kB. Proc Natl. Acad. Sci. USA. 86:2336.
53. Sen, R., and D. Baltimore. 1986a. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46:705.
54. Macchi, M., J.-M. Bomert, I. Davidson, M. Kanno, R. Rosales, M. Vigneron, J.-H. Xiao, C. Fromental, and P. Chambon. 1989. The SV40 TC-II (kB) enhanson binds ubiquitous and cell type specifically inducible nuclear proteins from lymphoid and non-lymphoid cell lines. EMBO (Eur. Mol. Biol. Organ.) J. 8:4215.
55. Kanno, M., C. Fromental, A. Staub, F. Ruffenach, I. Davidson, and P. Chambon. 1989. The SV40 TC-II (kB) and the related H-2KB enhansons exhibit different cell type specific and inducible protoenhancer activities, but the SV40 core sequence and the AP-2 binding site have no enhanson properties. EMBO (Eur. Mol Biol. Organ.) J. 8:4205.
56. Phares, W., and W. Herr. 1991. Functional similarity between human immunodeficiency virus type 1 and Simian Virus 40 kB protoenhancers. J. Virol. 65:2200.
57. Baeuerle, P.A., and D. Baltimore. 1988b. I/cB: A specific inhibitor of the NF-/cB transcription factor. Science (Wash. DC). 242:540.
58. Wong, G.H.W., J.H. Elwell, L.W. Oberley, and D.V. Goeddel. 1989. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell. 58:923.
59. Wong, G.H.W., and D.V. Goeddel. 1988. Induction of man-ganeous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science (Wish. DC). 241:941.
60. Sen, R., and D. Baltimore. 1986b. Inducibility of k immunoglobulin enhancer-binding protein by a posttranslational mechanism. Cell. 47:921.
61. Schreck, R., and P. A. Baeuerle. 1990. NF-kB as inducible transcriptional activator of the granulocyte-macrophage colony-stimulating factor gene. Mol. Cell. Biol. 10:1281.
62. Shakov, A.N., M.A. Collart, P. Vassalli, S.A. Nedospasov, and C.V. Jongeneel. 1990. KB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor a gene in primary macrophages. J. Exp Mel 171:35.
63. Collart, M.A., P.A. Baeuerle, and P. Vassalli. 1990. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four KB-like motifs and of constitutive and inducible forms of NF-kB. Mol. Cell Biol. 10:1498.
64. Rosenberg, Z.F., and A.S. Fauci. 1990. Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. Immunol. Today. 11:176.
65. Halliwell, B., and J.M.C. Gutteridge. 1989. Free Radicals in Biology and Medicine, 2nd Edition, Clarendon Press, Oxford.
66. Bauskin, A.R., I. Alkalay, and Y. Ben-Neriah. 1991. Redox regulation of a protein tyrosine kinase in the endoplasmic reticulum. Cell. 66:685.
67. Haskill, S., A.A. Beg, S.M. Tompkins, J.S. Morris, A.D. Yurochko, A. Sampson-Johannes, K. Mondai, P. Ralph, and A.S. Jr. Baldwin. 1991. Characterization of an immediate-early gene induced in adherent monocytes that encodes iKB-like activity. Cell. 65:1281.
68. Davis, N., S. Ghosh, D.L. Simmons, P. Tempst, H.-C. Liu, D. Baltimore, and H.R. Jr. Bose. 1991. Rel-associated pp40: An inhibitor of the Rel family of transcription factors. Science (Wash. DC). 253:1268.
69. Ghosh, S., and D. Baltimore. 1991. Activation in vitro of NF-kB by phosphorylation of its inhibitor IkB. Nature (Lond.). 344:678.
70. Negre-Salvayre, A., V. Reaud, C. Hariton, and R. Salvayre. 1991. Protective effect of a-tocopherol, ascorbic acid and rutin against peroxidative stress induced by oxidized lipoproteins on lymphoid cell lines. Biochem. Pharmacol. 42:450.
71. Storz, G., L.A. Tartaglia, and B.N. Ames. 1990. Transcriptional regulator of oxidative stress-inducible genes: direct activation by oxydation. Science (Wash. DC). 248:189.
72. Devary, Y., R.A. Gottlieb, L.F. Lau, and M. Karin. 1991. Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol. Cell. Biol. 11:2804.
73. Nose, K., M. Shibanuma, K. Kikuchi, H. Kageyama, S. Saki-yama, and T. Kuroki. 1991. Transcriptional activation of early-response genes by hydrogen peroxide in a mouse osteoblastic cell line. Eur. J. Biochem. 201:99.
74. Boyle, W.J., T. Smeal, L.H.K. Defize, P. Angel, J.R. Woodgett, M. Karin, and T. Hunter. 1991. Activation of protein kinase C decreases phosphorylation of c-jun at sites that negatively regulate its DNA-binding activity. Cell. 64:573.
75. Abate, C., L. Patel, F.J. Ill Rauscher, and T. Curran. 1990. Redox regulation of Fos and Jun DNA-binding activity in vitro. Science (Wash. DC). 249:1157.
76. Brach, M.A., R. Hass, M.L. Sherman, H. Gunji, R. Weisch-selbaum, and D. Kufe. Ionizing radiation induces expression and binding of the nuclear factor kB. 1991. J. Clin. Inuest. 88:691.
77. Tyrrell, R.M., 1920. UVA (320-380 nm) radiation as an oxidative stress. In Oxidative Stress: Oxidants and Antioxidants. H. Sies, editor. Academic Press Limited, London. 57-83.
78. Jakway, J.P., and A.L. deFranco. 1986. Pertussis toxin inhibition of B cell and macrophage responses to bacterial lipopoly-saccharide. Science (Wash. DC). 234:743.
79. Hohmann, H.-P., R. Kolbeck, R. Remy, and A.P.G.M. van Loon. 1991. Cyclic AMP-independent activation of transcription factor NF-kB in HL60 cells by tumor necrosis factor a and β. Mol. Celt. Biol. 11:2315.
80. Wightman, P.D., and C.R.H. Raetz. 1984. The activation of protein kinase C by biologically active lipid moieties of li-popolysaccharide. J. Biol. Chem. 259:10048.
81. Rosoff, P.M., N. Savage, and C.A. Dinarello. 1988. Interleukin-1 stimulates Diacylglycerol production in T lymphocytes by a novel mechanism. Cell. 54:73.